Transcript THERE IS A NEW AIR ABOUT INDIA”

“THERE IS A NEW AIR ABOUT
INDIA”
ISLANDS OF EXCELLENCE IN :
EDUCATION
• HEALTHCARE
•
INDUSTRY
AGRICULTURE
RESEARCH
ENGLISH`S NEW SUPERPOWER

WITH AN ENGLISH-SPEAKING POPULATION
NOW LIKELY TO HAVE SURPASSED THAT OF
BRITAIN AND THE US, INDIA IS SET TO
BECOME A LINGUISTIC SUPER POWER.

INDIA CURRENTLY HAS A SPECIAL PLACE IN
THE ENGLISH LANGUAGE RECORD BOOKS –
AS THE COUNTRY WITH THE LARGEST
ENGLISH SPEAKING POPULATION IN THE
WORLD. TEN YEARS AGO THAT RECORD WAS
HELD BY THE US . NOT ANY MORE !
INDIA ON TOP

AMONG THE FASTEST GROWING ECONOMIES
“FOURTH LARGEST ECONOMY”:
WASHINGTON POST

AMONG THE TOP FOUR FDI DESTINATIONS
MORE FII INTO INDIAN EQUITIES THAN CHINA, KOREA
& TAIWAN COMBINED
“ POTENTIALLY BIGGER LONG-TERM GROWTH STORY
THAN CHINA ”: GOLDMAN SACHS
INDIA ON TOP
ECONOMIST INTELLIGENCE UNIT (SEPT 04)
CENTERS OF OVERSEAS INVESTMENT :
%
COUNTRY
39
CHINA
29
USA
28
INDIA
“ INDIA AN R & D SPOT “
INDIA ON TOP
LARGEST MILKY WAY !
90 MILLION TONS IN 2004
 20 MILLION TONS MORE THAN USA,
THE SECOND BIG PRODUCER

INDIA ON TOP
NO.1 IN MANY AREAS !




SUGAR PRODUCTION
BANANA, PAPAYA, MANGO
EGG PLANT, CAULIFLOWER, PEAS
SPICES, COCONUT, ARECNUT
INDIA ON TOP


INDIAN BRANDY, BUT GLOBAL KICK
McDowell's NO.1 WORLD`S TOP SELLING
BRAND, DISPLACES E & J
INDIAN MULTINATIONALS
DESI COMPANIES GOBBLING UP FOREIGN
ENTITIES !




IN 2003, 40 COMPANIES TAKEN OVER
TATA TEA : TETLEY TEA
TATA : DAEWOO
ESSEL PACKAGING : PROPAK (SWISS)
BIGGEST CARBON BLACK :
KUMARAMANGALAM BIRLA
INDIA AN R & D POWERHOUSE
ENGLISH SPEAKING KNOWLEDGE
WORKERS
 30%-50% COST SAVING : SWATI
PIRAMAL
 1/5TH -1/7TH COST IN EUROPE : RANBAXY
 BANGALORE : FASTEST GROWING
BIOCLUSTER IN ASIA

THE BIOTECH INDUSTRY








MORE NEW DRUG APPROVALS FROM FDA BY
BT COMPANIES THAN PHARMA IN 2004
USA:THE BIRTHPLACE OF MODERN BT
TOWER OVER THE FIELD !
4400 BT FIRMS WORLDWIDE
2200 US FIRMS PUBLICLY TRADED
2004 REVENUES $43 BILLION
AMERICAN INDUSTRY RAISED $17 BILLION
FROM PUBLIC & PRIVATE FUNDS IN 2004
(5 TIMES THAT OF EUROPE !)
GERMAN BT FLOUNDERED
BRITISH BT BRUISED & BLOODIED BUT
UNBOWED (ERNST & YOUNG)
ASIAN BIOTECH

DOMINATED BY AUSTRALIA :$2 BN, i.e. 75 %
OF ASIAN REVENUE

INTERESTING COMPANIES SPRINGING UP IN
INDIA, CHINA, SINGAPORE
SINGAPORE BIOPOLIS

TO HOST 2000 SCIENTISTS FROM AROUND
THE WORLD INCLUDING ALLEN COLEMAN
OF DOLLY FAME

R & D BUDGET OF $ 7 BILLION OVER 5 YEARS

500 STUDENTS SENT ABROAD FOR Ph.D
INDIAN BIOTECH SECTOR





ABLE (ASSOC. BIOTECH LED ENTERPRISES)
REVENUE - $ 1 BILLION
FIVE FOLD INCREASE ($ 5 BILLION) BY 2010
EMPLOYED 9000 S & T PERSONNEL IN 2004
40% INCREASE IN 2005
PHARMA EXPORTS TO GROW
TO $6 bn
INDIA IS ONE OF THE TOP FIVE
MANUFACTURERS OF BULK DRUGS IN THE
WORLD !

PHARMA EXPORTS $6 bn BY 2015 FROM THE CURRENT LEVEL
OF LESS THAN $2 bn

THE R & D ACTIVITIES ARE TARGETED BOTH AT NEW DRUG
DISCOVERY RESEARCH AND NOVEL DRUG DELIVERY
SYSTEMS (NDDS). THE MAJOR COMPANIES INVESTED OVER
Rs. 1000 CRORES LAST YEAR.
INDIAN BIOTECH SECTOR
SERUM INSTITUTE
THE VACCCINE GIANT !





LARGEST INDIAN BT COMPANY
LARGEST VACCINE PRODUCER IN THE WORLD
PRODUCES 675 m DOSAGES PER DAY
DISTRIBUTED AND USED IN 137 COUNTRIES OF THE
WORLD (W.H.O)
30% OF WORLD`S CHILDREN PROTECTED BY
SERUM INTITUTE`S VACCINE
INDIAN BIOTECH SECTOR
INDIAN VACCINE IMPACT








HAFFKINE INSTITUTE , MUMBAI
PIONEER IN POLIO VACCINE PRODUCTION
IMMUNISED 150 m CHILDREN
ERADICATED POLIO
HEPATITIS B VACCINES
SHANTA BIOTECH
BHARAT BIOTECH
WOCKARDT, REDDY`S
INDIAN BIOTECH SECTOR
NEUTRACEUTICALS
PARRY NEUTRACEUTICALS
SPIRULINA, DUNALIELLA
-CAROTENE, ASTAXANTHIN
 THAPAR
 ABL BIOTECHNOLOGIES
 SAMY CHEMICALS

INDIAN BIOTECH SECTOR




EMERGING INTERNATIONAL HUB FOR
CONTRACT RESEARCH
MANY START-UP COMPANIES IN THE LAST
FOUR YEARS
BPO RPO
CRAM
RESEARCH &
MANUFACTURING
BIOCON (BANGALORE) SERUM INSTITUTE
(PUNE), PANACEA BIOTECH (DELHI),
NICHOLAS PIRAMAL (MUMBAI), NOVO
NORDSIK (BANGALORE)
APOLLO HOSPITAL ENTERPRISES








CHENNAI, DELHI, HYDERABAD
Rs 150 CRORE REVENUE IN 2004-2005
40% REVENUE FROM CARDIAC CARE
39% REVENUE FROM PHARMA BUSINESS
TO SET UP SEVEN 120 BED HOSPITALS IN MINIMETROS
MOU WITH JOHNS HOPKINS MEDICINE
INTERNATIONAL
TO SET UP CENTRAL REFERENCE LABS IN CHENNAI,
HYDERABAD AND DELHI - HIGH END CLINICAL
TESTING
TO SET UP INSTITUTE OF MINIMAL INVASIVE
SURGERY
COLLABORATIVE R & D





RANBAXY : MEDICINES FOR MALARIA
VENTURE (MMV) GENEVA
ANTIMALARIAL MOLECULE - Rbx 11160
RANBAXY : GLAXO SMITH KLINE
Dr. REDDY`S, ZYDUS CADILA,
NICHOLAS PIRAMAL (EMERGING
ACTIVITIES)
BIOCON TIES WITH NOBEX TO
DEVELOP ORAL INSULIN

BIOCON HAS ENTERED INTO A RESEARCH COLLABORATION
WITH NORTH CAROLINA`S NOBEX CORPORATION TO JOINTLY
DEVELOP ORAL INSLIN FOR THE GLOBAL AND INDIAN
MARKET
ORCHID CHEM`S IPR FILE COUNT TOUCHES 200
FILINGS FOR NEW DRUGS, DISCOVERY SYSTEMS AT
25% OF TOTAL
FIIS TO HIKE STAKE IN ORCHID CHEMICALS
ORCHID JOINS PAR PHARMA TO MARKET GENERICS IN
US
ORCHID WANTS TO CRACK ORAL CEPHALOSPORIN
FORMULATIONS MARKET
ORCHID FILES ANDA FOR CEFAZOLIN
ORCHID CHEMICALS &
PHARMACEUTICALS LTD.







300 SCIENTIFIC PERSONNEL
400 BY 2006
Rs. 150 CRORES IN R & D DURING LAST 7
YEARS
FDA/GLP ANIMAL FACILITY, LABS
ANTI-INFLAMATORY, OBESITY, CANCER,
HERBAL MEDICINE
TARGET : $1 bn BY 2010
JV IN USA, ITALY , CHINA
PEP PILL: GLOBAL BIZ FORM 60% OF SALES
NOW
WOCKHARDT EYES ANOTHER EUROPEAN
TAKEOVER
 AFTER ACQUIRING THREE EUROPEAN COMPANIES
IN THE PAST, IT IS LOOKING TO ACQUIRE ONE MORE
EUROPEAN COMPANY
 WOCKHARDT BUYS GERMAN FIRM
* DRL ACQUIRES TRIGENESIS OF US
 TORRENT PHARMA TO ACQUIRE GERMAN CO FOR Rs
300 CRORE
 JUBILANT ORGANOSYS ACQUIRES TWO BELGIAN
PHARMA FIRMS
 Rs 75 CRORE DEAL TO STRENGTHEN PRESENCE IN
EU, ITS MAIN EXPORT MARKET
 WYETH SELLS BULK DRUGS PLANT TO RUNWAL
GROUP FOR Rs 60 CRORE

NICHOLAS PIRAMAL PLANS BIG DIAGNOSTICS PUSH
HAS SIGNED ALLIANCES WITH DIASYS GMBH, A GERMAN FIRM,
HYPOGUARD, A UK-BASED COMPANY PART OF THE MEDISYS
GROUP, AND CHOLESTECH, A US-BASED COMPANY.
STRAND IN DEAL WITH US CO FOR MICROARRAY
PLATFORM
 HAS ENTERED INTO AN AGREEMENT WITH US MAJOR
AFFYMETRIX,
FOR PROVIDING MICROARRAY PLATFORM
 MICROARRAYS ARE POWERFUL TOOLS THAT ALLOW SCIENTISTS
TO MEASURE AND COMPARE THE EXPRESSION LEVELS OF
THOUSANDS OF GENES IN A SINGLE EXPERIMENT.
SHASUN HIKES CONTRACT THRUST
 USFDA-COMPLIANT R&D (RESEARCH AND DEVELOPMENT)
CENTRE NEAR CHENNAI AT AN INVESTMENT OF ABOUT RS.35
CRORE.
 THE NEW FACILITY WOULD HOUSE ABOUT EIGHT
LABORATORIES AND NEARLY 300 SCIENTISTS.
 MALLADI DRUGS ACQUIRES U.S. FIRM
 SUN PHARMA’S PLANS FOR US BUY GET A BOOST
 ZYDUS CADILA UPPING PRESENCE ABROAD
CLINICAL RESEARCH



$ 1 BILLION BY 2008
BIOCON – CLINIGENE
RELIANCE CLINICAL RESEARCH SERVICES
QUINTILES : WORLD`S
LARGEST CLINICAL RESEARCH
OUTFIT



IN INDIA SINCE 1997
MUMBAI, AHMEDABAD, BANGALORE
900 PEOPLE
2000 PEOPLE BY 2008
MERCK & CO $40 bn US GIANT

WITH APOTHECARIES LTD
(DELHI, CRO)

CLINICAL TRIALS ACROSS 20 CENTERS
IN INDIA FOR ANTIBIOTIC , CANCER
SRL-RANBAXY IN TIE-UP WITH UK
HOSPITALS GROUP

PATHOLOGY TESTING IN INDIA

NINE LABS IN INDIA, MAIN LAB IN
MUMBAI
CCMB SPOTS GENETIC JACKPOT IN INDIA
 WITH ITS 4,635 ANTHROPOLOGICALLY WELL-DEFINED
ENDOGAMOUS POPULATIONS –
OF WHICH 532 ARE TRIBES, INCLUDING 72 PRIMITIVE
POPULATIONS, INDIA IS A BIGGER LABORATORY THAN ICELAND
TO STUDY POPULATION/COMMUNITY-BASED GENETIC DISEASES.
 BIOCON CHAIRMAN KIRAN MAZUMDAR-SHAW ARGUES THAT THE
COUNTRY’S UNIQUE GENE POOLS ARE “GOLD MINES”.
 ABOUT 50 MILLION INDIVIDUALS ARE AFFECTED WITH GENETIC
DISEASES IN INDIA.
GSK BIO TARGETS INDIA FOR R & D

GLAXO SMITH KLINE BIOLOGICALS, THE VACCINE
BUSINESS OF GLAXO SMITH KLINE (GSK), WILL
MAKE INDIA A GLOBAL HUB FOR CLINICAL
RESEARCH AND DEVELOPMENT

HI-TECH VACCINES FOR AIDS, DENGUE, MALARIA
AND TB

THE TB VACCINE TO START PHASE II TRIALS IN
INDIA
 PEP PILL:SANDOZ INVESTS $13M IN THIRD FACILITY IN INDIA.
 ROCHE DIAGNOSTICS EYES INDIA FOR PRODUCTION, R&D.
GE HEALTHCARE
SOME OF US GROW UP TO BE ENGINEERS OR
DOCTORS
SOME OF US GROW UP TO BE BOTH !





MEDICAL IMAGING AND INFORMATION TECHNOLOGIES
MEDICAL DIAGNOSTICS
PATIENT MONITORING SYSTEMS, DISEASE RESEARCH,
DRUG DISCOVERY AND BIOPHARMACEUTICALS
EARLY DETECTION OF DISEASE AND TREATMENT OF
CONDITIONS LIKE CANCER, ALZHEIMER`S AND
CARDIOVASCULAR DISEASES
GTO INDIA HAS OVER 90 PATENTS TO ITS CREDIT AND OVER
100 INVENTION DISCLOSURES IN THE YEAR 2003 ALONE.
GENETICS SPECIALTIES
LAUNCHED

CANCER GENETICS, A BIOTECHNOLOGY
COMPANY BASED IN THE US, HAS
ANNOUNCED THE LAUNCH OF GENETICS
SPECIALTIES IN BANGALORE.

GENETIC DIAGNOSTIC TOOL FOR INDIAN
HEALTH MARKET
GM RESEARCH THRIVING IN
INDIAN ACADEMIA
WHEAT, RICE, SUGARCANE, TOBACCO BANANA,
VEGIES, POTATO, OIL SEEDS
$15 MILLION/YEAR GOVT. LABS
Vs
$ 10 MILLION/ YEAR BY SEED COST,
20 GOVT. INSTITUTES ON 16 CROPS
SEVERAL PRIVATE COMPANIES ON 10 CROPS
IARI, JNU, NCPGR, U. DELHI, MKU, SRI (CBE), NBRI,
TNAU, ICRISAT.
ICRISAT, HYDERABAD

WORLD`S FIRST TRANSGENIC GROUNDNUT:
RESISTANCE TO INDIAN PEANUT CLAMP
VIRUS ; ROSETTE DISEASE IN AFRICA

TRANSGENIC BT PIGEONPEA, CHICKPEA
GM CROPS RESEARCH IN INDIA






RALLIS INDIA (TATAS)
RASI, NUSIVEEDU, NAVBHARAT, ANKUR,
METAHELIX, AVESTHAGEN
INDO-AMERICAN HYBRID SEEDS
MONSANTO/MAHICO
SYNGENTA (SWISS)
BAYER/ PROAGRO(GERMANY)
GM COTTON WILL TREBLE
TO 3.3 m Acres !
(FROM 1.0 m Acres)



INDIA LARGEST COTTON ACREAGE
BUT VERY LOW PRODUCTION/ACRE
GM SURGE MOSTLY ILLEGAL PLANTING
THE LAS VEGAS PILL




PFIZER`S ANGINA DRUG TEST !
MALE VOLUNTEERS NOTED UNUSUAL
CONSEQUENCE
COMPOUND UK - 92480 BECAME VIAGRA
USE OF DOPAMINE AGONISTS : COMPULSIVE
GAMBLERS, ALCOHOLICS, GLUTTONS, SEX
PESTS
BORED WITH BREAD AND BUTTER
BIOTECH !
GO MAKE GREAT WINES !




SIX BANKERS (INCLUDING TWO INDIANS)
LEGENDARY MEAL AT CELEBRATED CHEF
GORDON RAMSAY`S PETRUS RESTAURANT IN
LONDON: SPLASHED £ 44000
CERTIFIED MOST EXPENSIVE MEAL BY
GUINESS BOOK OF RECORDS
1947 CHATEAU PETRUS BORDEAUX : £12300
(Rs.10 LAKHS)
TWO WINES : £ 11600 AND £ 9400
NICHOLAS PIRAMAL PLANS BIG DIAGNOSTICS PUSH
HAS SIGNED ALLIANCES WITH DIASYS GMBH, A GERMAN FIRM,
HYPOGUARD, A UK-BASED COMPANY PART OF THE MEDISYS
GROUP, AND CHOLESTECH, A US-BASED COMPANY.
INDIA ON TOP
RELIANCE INDUSTRIES IS THE WORLD`S :




2ND LARGEST PRODUCER OF POLYFIBER AND YARN
3RD LARGEST PRODUCER OF PARAXYLENE
5TH LARGEST PRODUCER OF PURIFIED TEREPTHALIC ACID (PTA)
IT COMBINES THE PEPTIDE PRODUCTION CAPABILITIES OF BIOCON WITH
THE PEPTIDE BASED ORAL-DELIVERY TECHNOLOGY OF NOBEX.

BIOCON TIES UP WITH VACCINEX FOR ANTIBODIES

BIOCON WITH ROCHESTER (NEW YORK) - BASED VACCINEX TO PURSUE
DEVELOPMENT OF THERAPEUTIC MONOCLONAL ANTIBODIES (MAbs) TO
ADD TO THEIR DISCOVERY PIPELINE.

GLOBAL PROJECTED SALES OF MAbs IS EXPECTED TO TOUCH $13 bn BY
2010
THE SCRIPTING OF INDIA NO.1
THE LIST OF DESI COS POSSESSING WORLD CLASS SIZE AND SCALES GROWING

UB GROUP, WHICH WITH THE ACQUITION OF SHAW WALLACE HAS BECOME THE
SECOND LARGEST LIQUOR COMPANY IN THE WORLD AFTER DIAGEO

HERO HONDA IS SET TO END THE CURRENT FISCAL AS THE LARGEST TWO WHEELER
COMPANY IN THE WORLD FOR THE FOURTH YEAR IN SUCCESSION.

HERO GROUP COMPANY, HERO CYCLES, IS THE LARGEST COMPANY WITH ANNUAL
PRODUCTION OF 5.4 mn BICYCLES

ESSEL PROPACK IS THE WORLD`S LARGEST MANUFACTURER OF LAMINATED TUBES.

GLOBAL MARKETSHARE OF MORE THAN 30%, HAS MANUFACTURING FACILITIES IN
CHINA,USA,GERMANY,MEXICO,COLUMBIA, VENEZUELA, PHILIPPINES, INDONESIA,
EGYPT AND NEPAL.

BHARAT FORGE IS THE WORLD`S SECOND LARGEST COMPANY

SUNDARAM FASTENERS IS THE WORLD`S THIRD LARGEST BRAKE LINING, FASTENER
AND RADIATOR CAPS MANUFACTURERS

TATA TEA AND ITS SUBSIDIARY TATA TETLEY TOGETHER CONSTITUTE THE SECOND
LARGEST BRANDED PORTFOLIO IN THE WORLD.
STRAND IN DEAL WITH US CO FOR
MICROARRAY PLATFORM
 HAS ENTERED INTO AN AGREEMENT WITH US MAJOR AFFYMETRIX,
FOR PROVIDING MICROARRAY PLATFORM
MICROARRAYS ARE POWERFUL TOOLS THAT ALLOW SCIENTISTS
TO MEASURE AND COMPARE THE EXPRESSION LEVELS OF
THOUSANDS OF GENES IN A SINGLE EXPERIMENT.
CONTRACT RESEARCH AND
AMNUFACTURING(CRAM)









TCS
INFOSYS
WIPRO
HCL TECHNOLOGIES
ITTIAM
SASKEN
BIOCON
SHASUN
DIVI`S
INDIAN MULTINATIONALS
MANY INDIAN COMPANIES IN DRAGON
COUNTRY !



INFOSYS, TCS, SUNDARAM FASTENERS,
BHARAT FORGE
RANBAXY NOW SELLS MORE ABROAD THAN
IN INDIA
HAS SUBSIDIES IN MORE THAN 12
COUNTRIES
SHASUN HIKES CONTRACT THRUST
 USFDA-COMPLAINT R&D (RESEARCH AND DEVELOPMENT)
CENTRE NEAR CHENNAI AT AN INVESTMENT OF ABOUT RS.35
CRORE.
 THE NEW FACILITY WOULD HOUSE ABOUT EIGHT
LABORATORIES AND NEARLY 300 SCIENTISTS.
CCMB SPOTS GENETIC JACKPOT IN INDIA
 WITH ITS 4,635 ANTHROPOLOGICALLY WELL-DEFINED
ENDOGAMOUS POPULATIONS-OF WHICH 532 ARE TRIBES,
INCLUDING 72 PRIMITIVE POPULATIONS, INDIA IS A BIGGER
LABORATORY THAN ICELAND TO STUDY
POPULATION/COMMUNITY-BASED GENETIC DISEASES.
 BIOCON CHAIRMAN KIRAN MAZUMDAR-SHAW ARGUES THAT
THE COUNTRY’S UNIQUE GENE POOLS ARE “GOLD MINES”.
 ABOUT 50 MILLION INDIVIDUALS ARE AFFECTED WITH
GENETIC DISEASES IN INDIA.
 PEP PILL : SANDOZ INVESTS $13M IN THIRD FACILITY IN INDIA.
 ROCHE DIAGNOSTICS EYES INDIA FOR PRODUCTION, R&D.